Cargando…

Anti-infliximab antibodies and clinical response in noninfectious uveitis and scleritis patients treated with infliximab: A retrospective review

PURPOSE: To investigate the clinical response to infliximab in ocular inflammation patients who develop anti-infliximab antibodies (AIA) vs. those patients who do not develop AIA. OBSERVATIONS: A retrospective review was performed of patients treated with infliximab for noninfectious uveitis (NIU) o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Valdes, Lianna, Cox, Jacob T., Yang, Janine, Susarla, Gayatri, Han, Samuel, Papaliodis, George N., Sobrin, Lucia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9253593/ https://www.ncbi.nlm.nih.gov/pubmed/35800400 http://dx.doi.org/10.1016/j.ajoc.2022.101634

Ejemplares similares

Infliximab for the treatment of refractory scleritis
por: Doctor, Priyanka, et al.
Publicado: (2009)

The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies
por: Xiong, Anji, et al.
Publicado: (2021)

Combined Infliximab and Rituximab in Necrotising Scleritis
por: Morarji, Jiten, et al.
Publicado: (2012)

Management of noninfectious scleritis
por: Abdel-Aty, Ahmad, et al.
Publicado: (2022)

Infliximab to treat chronic uveitis in juvenile idiopathic arthritis (JIA)
por: Bracaglia, C, et al.
Publicado: (2008)

New onset or exacerbation of uveitis with infliximab: paradoxical effects?
por: Iwahashi, Chiharu, et al.
Publicado: (2019)

Antibodies toward infliximab are associated with low infliximab concentration at treatment initiation and poor infliximab maintenance in rheumatic diseases
por: Ducourau, Emilie, et al.
Publicado: (2011)

Infliximab in the treatment of refractory uveitis. Does dose really matter?
por: Sukumaran, MD Sukesh, et al.
Publicado: (2011)

Systematic review of studies comparing infliximab and adalimumab in autoimmune uveitis
por: Mase, Oliver, et al.
Publicado: (2023)

The relationship between infliximab concentrations, antibodies to infliximab and disease activity in Crohn's disease
por: Vande Casteele, Niels, et al.
Publicado: (2015)

Serum Levels of Infliximab and Anti-Infliximab Antibodies in Brazilian Patients with Crohn's Disease
por: Gomes, Luis Eduardo Miani, et al.
Publicado: (2019)

Development of anti-infliximab antibody is associated with reduced efficacy and infusion reaction in Behçet's disease with uveitis
por: Ishigatsubo, Y, et al.
Publicado: (2015)

Biologics for the treatment of noninfectious uveitis
por: Lin, Chang-Ping
Publicado: (2018)

Intraocular therapy in noninfectious uveitis
por: Modugno, Rocco Luigi, et al.
Publicado: (2021)

Outcomes of Escalating Immunosuppressive Treatments for Recalcitrant Noninfectious Posterior Scleritis
por: Pan, Yuan, et al.
Publicado: (2022)

Low infliximab serum trough levels and anti-infliximab antibodies are prevalent in rheumatoid arthritis patients treated with infliximab in daily clinical practice: results of an observational cohort study
por: van der Maas, Aatke, et al.
Publicado: (2012)

High Dose Infliximab in the Treatment of Refractory Uveitis: Does Dose Matter?
por: Sukumaran, Sukesh, et al.
Publicado: (2012)

Tofacitinib for refractory uveitis and scleritis
por: Paley, Michael A., et al.
Publicado: (2018)

Low Dose Infliximab for Prevention of Postoperative Recurrence of Crohn’s Disease: Long Term Follow-Up and Impact of Infliximab Trough Levels and Antibodies to Infliximab
por: Sorrentino, Dario, et al.
Publicado: (2015)

Potential Biomarkers for Noninfectious Scleritis Identified by Serum and Tear Fluid Proteomics
por: Vergouwen, Daphne P.C., et al.
Publicado: (2023)

Clinical correlations of infliximab trough levels and antibodies to infliximab in South Korean patients with Crohn’s disease
por: Oh, Eun Hye, et al.
Publicado: (2017)

Voclosporin as a Treatment for Noninfectious Uveitis
por: Schultz, Clyde
Publicado: (2013)

Targeting interleukin-6 for noninfectious uveitis
por: Lin, Phoebe
Publicado: (2015)

Reconstitution of disrupted photoreceptor layer in uveitis associated with Behçet’s disease by infliximab treatment
por: Takeuchi, Masaru, et al.
Publicado: (2015)

Infliximab to treat Crohn’s disease: an update
por: Cottone, M, et al.
Publicado: (2011)

Infusion reaction to infliximab biosimilar after transitioning from infliximab
por: Kashlan, Reem, et al.
Publicado: (2020)

Rituximab for non-infectious Uveitis and Scleritis
por: Ng, Caleb C., et al.
Publicado: (2021)

Ten-year follow-up of infliximab treatment for uveitis in Behçet disease patients: A multicenter retrospective study
por: Takeuchi, Masaru, et al.
Publicado: (2023)

Comparison of Intestinal Microbes in Noninfectious Anterior Scleritis Patients With and Without Rheumatoid Arthritis
por: Li, Mengyao, et al.
Publicado: (2022)

Scleral Proteome in Noninfectious Scleritis Unravels Upregulation of Filaggrin-2 and Signs of Neovascularization
por: Vergouwen, Daphne P. C., et al.
Publicado: (2023)

Use of Adalimumab in young patients with chronic uveitis in whom infliximab loses its efficacy
por: Giani, TG, et al.
Publicado: (2008)

A 10-year follow-up of infliximab monotherapy for refractory uveitis in Behçet’s syndrome
por: Horiguchi, Noe, et al.
Publicado: (2020)

Switching and Discontinuation Patterns Among Patients Stable on Originator Infliximab Who Switched to an Infliximab Biosimilar or Remained on Originator Infliximab
por: Fitzgerald, Timothy, et al.
Publicado: (2021)

Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays
por: Afonso, Joana, et al.
Publicado: (2016)

Clinical Outcomes of Cyclosporine Treatment for Noninfectious Uveitis
por: Lee, Sun Ho, et al.
Publicado: (2012)

Dexamethasone intravitreal implant for the treatment of noninfectious uveitis
por: Hunter, Rebecca S, et al.
Publicado: (2011)

New pharmacotherapy options for noninfectious posterior uveitis
por: Pleyer, Uwe, et al.
Publicado: (2021)

Noninfectious Uveitis in Rheumatology: Patterns, Treatment, and Outcomes
por: Younus, Raheel, et al.
Publicado: (2023)

Infliximab and biosimilar infliximab in psoriasis: efficacy, loss of efficacy, and adverse events
por: Subedi, Smriti, et al.
Publicado: (2019)

Impact of Introducing Infliximab Biosimilars on Total Infliximab Consumption and Originator Infliximab Prices in Eight Regions: An Interrupted Time-Series Analysis
por: Peng, Kuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_bqpojojugmemt84aj1bqhghsrm